Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.

TSXV:TLT - Post by User

Theralase Technologies Inc. > New Email from MP

<< Previous

Bullboard Posts

Next >>

Comment by menoalittleon Dec 31, 2024 5:09pm

168 Views

Post# 36382912

RE:RE:New Email from MP

What did you expect him to say in the email?

That they already met with the FDA and are sending the BTD application in tomorrow?
Or maybe you wanted to hear that all that was done last week, and they expect to get BTD approval tomorrow?

Geeshhh....

Cool your jets, man.

<< Previous

Bullboard Posts

Next >>

Bragg’s iGaming platform drops in Brazil